title: HPV vaccine impact in Australian women: ready for an HPV-based screening program.
authors.affiliation: Victorian Cytology Service, Melbourne, VIC jbrother@vcs.org.au.
authors.forename: Julia Ml
authors.initials: JM
authors.lastname: Brotherton
authors.affiliation: Victorian Cytology Service, Melbourne, VIC.
authors.forename: Dorota M
authors.initials: DM
authors.lastname: Gertig
authors.affiliation: Victorian Cytology Service, Melbourne, VIC.
authors.forename: Cathryn
authors.initials: C
authors.lastname: May
authors.affiliation: Victorian Cytology Service, Melbourne, VIC.
authors.forename: Genevieve
authors.initials: G
authors.lastname: Chappell
authors.affiliation: Victorian Cytology Service, Melbourne, VIC.
authors.forename: Marion
authors.initials: M
authors.lastname: Saville
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D003430:Cross-Sectional Studies; D005260:Female; D061809:Human Papillomavirus DNA Tests; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 / Q000008:administration & dosage*; D006801:Humans; D008403:Mass Screening; D011230:Precancerous Conditions / Q000453:epidemiology / Q000517:prevention & control; D016896:Treatment Outcome; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology / Q000517:prevention & control; D014626:Vaginal Smears; D014739:Victoria; D055815:Young Adult
chemical_list: D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18